Journal of Peking University(Health Sciences) ›› 2017, Vol. 49 ›› Issue (6): 961-964. doi: 10.3969/j.issn.1671-167X.2017.06.005

• Article • Previous Articles     Next Articles

Expression of serum IgG4 in patients with different diseases

ZHANG Yi-lan1,2, WANG Zhi-feng1, CHEN Ning1△   

  1. (1. Department of Gastroenterology,Peking University People’s Hospital, Beijing 100044, China; 2. Department of Gastroenterology, People’s Hospital of Zhengzhou, Zhengzhou 450003, China)
  • Online:2017-12-18 Published:2017-12-18
  • Contact: CHEN Ning E-mail:chenning79@139.com

Abstract: Objective: To investigate serum IgG4 levels in different diseases and the changes of serum IgG4 levels in post  treatment of IgG4 related disease. Methods: Clinical data of 620 patients who received investigation of serum IgG4 in Peking University People’s Hospital from January 1, 2015 to March 31, 2016 were collected retrospectively. According to the difference of the diseases ,they were divided into common group of diseases, autoimmune diseases and IgG4 related diseases; pancreatic disease patients were divided into autoimmune pancreatitis and pancreatic cancer group; According to different treatment stages of the disease, the patients with IgG4 related diseases were divided into pretreatment group and post treatment  group. And  the expressions of the patients’ serum IgG4 levels in different groups were analyzed. Results: The median serum IgG4 level in the group of the patients with common diseases was 0.480(0.005, 50.400) g/L, in the group of autoimmune disease was 0.406 (0.003, 18.700) g/L , in the group of IgG4 related diseases was 5.200(0.046, 46.000)g/L, which was significantly higher in the group of IgG4 related diseases than the other two groups, and there was obvious statistical significance in serum IgG4 levels between the group of IgG4 related diseases and  the other two groups (P<0.01); There was no obvious difference in serum IgG4 levels between the common disease group and the autoimmune disease group, and there was no obvious statistical difference in serum IgG4 levels between the two groups (P>0.05).In the patients with IgG4 related diseases, the median serum IgG4 level in the group of pretreatment  patients was 6.540 (1.330, 34.100) g/L , and 3.735 (0.063, 46.000) g/L in the post treatment patients.   Serum IgG4 levels decreased in post treatment group, significantly lower than in pretreatment, there was obvious statistical difference in serum IgG4 levels between the two groups (P<0.01).The median serum IgG4 level in the group of patients with autoimmune pancreatitis was 3.735 (0.063, 46.000) g/L ,and 0.438 (0.056, 1.130) g/L in the group of patients with pancreatic cancer,which was significantly higher in the group of patients with autoimmune pancreatitis than the others, and there was obvious statistical difference in serum IgG4 levels between the two groups (P<0.01). Conclusion: Serum IgG4 levels in patients with different diseases were different, and were significantly higher in patients with autoimmune pancreatitis and IgG4 related diseases, so serum IgG4 levels can provide the basis for the differential diagnosis of different diseases; Serum IgG4 levels in patients with IgG4 related diseases decrease significantly after treatment, so it can be used as an important index to evaluate the curative effect of IgG4 related diseases.

Key words: IgG4, IgG4 related disease, Autoimmune diseases, Serum

CLC Number: 

  • R593
[1] Lu FENG,Jia-yu ZHAI,Jin-xia ZHAO. Medical visit status and clinical features in patients with IgG4 related disease [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1028-1032.
[2] Min FENG,Zhe CHEN,Yong-jing CHENG. A case of duodenal ulcer as prominent manifestation of IgG4-related disease [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1125-1129.
[3] Xue-ping WANG,Yu-ya-nan ZHANG,Tian-lan LU,Zhe LU,Zhe-wei KANG,Yao-yao SUN,Wei-hua YUE. Variations in fecal microbiota of first episode schizophrenia associated with clinical assessment and serum metabolomics [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 863-873.
[4] YU Guang-yan,LIU Deng-gao,LI Wei,HONG Xia,ZHANG Yan-yan,ZHU Wen-xuan,ZHANG Ke-fu,LI Xiao,LI Zhan-guo,LIU Yan-ying,CHEN Yan,GAO Yan,SU Jia-zeng. Studies on newly recognized chronic sialadenitis [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 13-17.
[5] Yi-ming ZHENG,Hong-jun HAO,Yi-lin LIU,Jing GUO,Ya-wen ZHAO,Wei ZHANG,Yun YUAN. Correlation study on anti-Ro52 antibodies frequently co-occur with other myositis-specific and myositis-associated autoantibodies [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1088-1092.
[6] Feng-yun-zhi ZHU,Xiao-yan XING,Xiao-fei TANG,Yi-min LI,Miao SHAO,Xue-Wu ZHANG,Yu-hui LI,Xiao-lin SUN,Jing HE. Clinical and immunological characteristics of myositis complicated with thromboembolism [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 995-1000.
[7] Jiao-niu DUAN,Wei DU,Rui-hong HOU,Ke XU,Gai-lian ZHANG,Li-yun ZHANG. Progressive necrosis of lipid: A case report [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1182-1184.
[8] Zi-qiao WANG,Yan-ying LIU,Xia ZHANG,Tian LIU,Li-min REN,Dan-hua SHEN,Yi WANG,Zhan-guo LI. Analysis of the clinical features and misdiagnosis reasons of 17 patients misdiagnosed with IgG4-related disease [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1025-1031.
[9] Hong-xia YANG,Xiao-lan TIAN,Wei JIANG,Wen-li LI,Qing-yan LIU,Qing-lin PENG,Guo-chun WANG,Xin LU. Clinical and pathological characteristics of immune mediated necrotizing myopathy [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 989-995.
[10] Jia-yu WANG,Mei-ping ZHAO. Fluorescence assay for the detection of apurinic/apyrimidinic endonuclease 1 (APE1) activity in human blood samples [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 487-492.
[11] Guang-ya YU,Xia HONG,Wei LI,Yan-yan ZHANG,Yan GAO,Yan CHEN,Zu-yan ZHANG,Xiao-yan XIE,Zhan-guo LI,Yan-ying LIU,Jia-zeng SU,Wen-xuan ZHU,Zhi-peng SUN. Clinicopathological characteristics and diagnosis of IgG4-related sialadenitis [J]. Journal of Peking University(Health Sciences), 2019, 51(1): 1-3.
[12] Xing-yun ZHU,Yan-ying LIU,Xue-juan SUN,Ping YU,Shuang LIU,Mei-yan FU,Xu LIU,Li-min REN,Zhan-guo LI. A cross-sectional study of the clinical features and physician visit patterns at onset of immunoglobulin G4 related disease [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1039-1043.
[13] WU Peng-hui, XIE Yao, ZHAO Wei-hong, HUA Ying, SUN Qing, LI Shuo, WU Ye, LU Xin-tian. Clinical characteristics analysis of children with reversible posterior leukoen-cephalopathy syndrome during the treatment of hematological tumor [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 662-665.
[14] FENG Yong-liang, FAN Jing-hui, LIN Xian-juan, YANG Ji-chun, CUI Qing-hua, TANG Xin-jing, XU Guo-heng, GENG Bin. Facilitating the measurement of circulatory hydrogen sulfide with fluorescence probe-coated microplates [J]. Journal of Peking University(Health Sciences), 2017, 49(6): 1060-1065.
[15] YU Jian-feng, JIN Yue-bo, HE Jing, AN Yuan, LI Zhan-guo. Changes of serum Krebs von den Lungen-6 levels in interstitial lung disease associated with dermatomyositis and secondary Sjögren’s syndrome: a case report [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 910-914.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!